Theodore Feldman

Summary

Publications

  1. ncbi request reprint Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals
    Theodore Feldman
    Miami Research Associates, Coral Gables, Florida 33146, USA
    Am J Cardiol 93:1481-6. 2004
  2. ncbi request reprint Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials
    Theodore Feldman
    Miami Research Associates, Coral Gables, Florida 33146, USA
    Clin Ther 28:849-59. 2006
  3. ncbi request reprint Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome
    Theodore Feldman
    Miami Research Associates, Coral Gables, Florida
    Metab Syndr Relat Disord 5:13-21. 2007

Detail Information

Publications3

  1. ncbi request reprint Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals
    Theodore Feldman
    Miami Research Associates, Coral Gables, Florida 33146, USA
    Am J Cardiol 93:1481-6. 2004
    ....
  2. ncbi request reprint Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials
    Theodore Feldman
    Miami Research Associates, Coral Gables, Florida 33146, USA
    Clin Ther 28:849-59. 2006
    ..Despite the need for effective and well-tolerated lipid-lowering therapies for primary hypercholesterolemia in older patients, there is a relative paucity of published data on such treatments in this population...
  3. ncbi request reprint Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome
    Theodore Feldman
    Miami Research Associates, Coral Gables, Florida
    Metab Syndr Relat Disord 5:13-21. 2007
    ..Conclusion: EZE/SIMVA significantly improved the lipid and inflammatory profiles of hypercholesterolemic patients with MetS and was well tolerated. Thus, EZE/SIMVA offers an efficacious and safe treatment option for these patients...